Bulevirtide is a synthetic lipopeptide drug used for the treatment of chronic hepatitis delta virus (HDV) infection in adult patients with compensated liver disease. This first-in-class antiviral agent… Read more
Bulevirtide is a synthetic lipopeptide drug used for the treatment of chronic hepatitis delta virus (HDV) infection in adult patients with compensated liver disease. This first-in-class antiviral agent functions as an entry inhibitor by binding to the sodium taurocholate cotransporting polypeptide (NTCP) receptor on hepatocytes, effectively preventing viral entry. For laboratories performing quality control and analytical testing of this complex peptide, high-quality reference standards are essential. This category provides access to Bulevirtide reference standards, including related impurities, known metabolites, and stable isotope-labelled compounds. These materials are critical for accurate impurity profiling, method validation, and ensuring the precision of analytical procedures throughout the drug development and manufacturing lifecycle.